Fu, Ci
Zhang, Xiang http://orcid.org/0000-0002-5916-1357
Veri, Amanda O.
Iyer, Kali R.
Lash, Emma
Xue, Alice
Yan, Huijuan
Revie, Nicole M.
Wong, Cassandra
Lin, Zhen-Yuan
Polvi, Elizabeth J.
Liston, Sean D. http://orcid.org/0000-0002-6218-2247
VanderSluis, Benjamin http://orcid.org/0000-0002-0299-5617
Hou, Jing
Yashiroda, Yoko
Gingras, Anne-Claude http://orcid.org/0000-0002-6090-4437
Boone, Charles http://orcid.org/0000-0002-3542-6760
O’Meara, Teresa R. http://orcid.org/0000-0002-8901-0154
O’Meara, Matthew J. http://orcid.org/0000-0002-3128-5331
Noble, Suzanne
Robbins, Nicole
Myers, Chad L. http://orcid.org/0000-0002-1026-5972
Cowen, Leah E. http://orcid.org/0000-0001-5797-0110
Funding for this research was provided by:
Foundation for the National Institutes of Health (R01AI127375)
Article History
Received: 5 August 2021
Accepted: 22 October 2021
First Online: 11 November 2021
Competing interests
: L.E.C. is a co-founder and shareholder in Bright Angel Therapeutics, a platform company for the development of novel antifungal therapeutics. L.E.C. is a consultant for Boragen, a small-molecule development company focused on leveraging the unique chemical properties of boron chemistry for crop protection and animal health. All other authors declare no competing interests.